Latest stories on TOI
Celyad Oncology Discloses Drop in Tolefi Stake Below 10% Threshold
TipRanks42 · neutralgeneral
AllyGPO Appoints Dustin Faircloth President of AllyOncology
PR Newswire59 · neutralgeneral
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
Business Insider50 · neutralearnings
Agilent Expands Precision Oncology Reach: EU Approves PD-L1 Diagnostic for Ovarian and Related Cancers
July 23, 2026
MarketChameleon73 · bullishproduct/pr
Is Oncology Institute (TOI) One of the Best Future Stocks to Buy Under $10?
Yahoo Top57 · neutralanalyst
Oncology Institute Refinances Debt with New Term Loan
TipRanks58 · neutralgeneral
Oncology Institute, Inc. (TOIIW) files 8-K
SEC 8-K50 · neutralgeneral
Why Oncology Institute’s (TOI) Analyst Upgrades Put Its Community Cancer Care Growth Story in Focus
Yahoo Top67 · bullishanalyst
Global Oncology-Based In-Vivo CRO Market to Accelerate Substantially at a CAGR of ~8% by 2034 | DelveInsight
PR Newswire63 · neutralgeneral
FACIT Expands with Expert Investment Committee to Grow its Oncology Portfolio
PR Newswire63 · neutralgeneral
Leerink Partners Expands Oncology Research Team with Addition of Asthika Goonewardene
PR Newswire57 · neutralgeneral
Karmanos Cancer Institute Reaches Historic Growth Milestone, Positioning Itself as a Leader in Oncology Care Delivery
PR Newswire63 · neutralproduct/pr
Oncology Institute, Inc. (TOIIW) files 8-K
SEC 8-K50 · neutralgeneral
Coiled Therapeutics to showcase oncology pipeline at London investor forum
TipRanks56 · neutralproduct/pr
OSE Immunotherapeutics SA (ORPOF) Discussion of Tedopi Immunotherapy Pipeline and Clinical Progress Across Oncology Indications Transcript
Seeking Alpha59 · neutralproduct/pr
CEO Sells 34K Shares of Biotech Stock, Valued at $615,000, According to Latest SEC Filing
The Motley Fool42 · neutralgeneral
Exigent Research Network Welcomes Nina Chavez as Senior Vice President of Growth
PR Newswire58 · neutralproduct/pr
Diakonos Oncology Shares Updated DOC1021 GBM Survival Data and Unveils Melanoma Clinical Study at ASCO 2026
PR Newswire67 · bullishproduct/pr
CEO Statement to Shareholders | OSRH Stock News
StockTitan54 · neutralproduct/pr
Topicus.com Inc. Announces a Revised Proposal to Acquire ReadyTech
GlobeNewswire56 · neutralm&a
Massive Bio to Unveil Reticulum Nexus™ as the AI Operating System for Oncology Access at ASCO 2026
Morningstar56 · neutralproduct/pr